Abstract
We report the unique case of a nine-month old patient diagnosed with B- Cell Acute Lymphoblastic Leukemia also positive for Hepatitis C virus, genotype 3 and a high viral load. With no existent literature to guide treatment of Hepatitis C in context of Infant Leukemia, treatment with direct-acting antivirals was deferred. A conservative approach to Hepatitis C was sought while he was undergoing chemotherapy, with the expectation of a spontaneous viral clearance, as has been documented for a quarter of otherwise healthy infants.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 31-33 |
| Number of pages | 3 |
| Journal | Pediatric Hematology Oncology Journal |
| Volume | 3 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Mar 2018 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Direct acting antivirals
- Hepatitis C
- Infant leukemia
Fingerprint
Dive into the research topics of 'Hepatitis C at presentation in a newly diagnosed infant with B Acute Lymphoblastic Leukemia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver